數位病理市場：按產品類型、治療領域、技術、最終用戶和地區分類

據估計，2026年數位病理市場規模為12.508億美元，預計到2033年將達到28.35億美元。預計2026年至2033年，該市場將以12.4%的複合年成長率成長。

數位病理學是指使用全玻片掃描器將玻片數位化，然後分析數位影像的過程，通常使用電腦顯示器或行動裝置上的影像檢視器進行分析。數位病理學提供更佳的檢視體驗，提高分析準確性，進而降低診斷錯誤率。此外，這些工具使服務供應商能夠即時參考和比較既往病例。這些先進的系統儲存數據，用於長期預測分析。檢體帶有條碼，以減少誤判的可能性，同時也消除了因玻片損壞而導致資料遺失的擔憂。在現代，數位病理學具有許多優勢，包括提高疾病診斷的準確性、縮短恢復時間以及提高病理學家的工作效率。由於這些優勢，醫療機構擴大使用數位病理學平台進行疾病診斷，主要市場參與者也紛紛推出相關產品。

市場動態

預計在預測期內，利用新技術開發創新數位病理平台將推動全球數位病理市場的成長。例如，2022年6月，軟體公司Tribun Health發布了TeleSlide Patho 5，這是一個用於共用數位病理切片和其他多媒體文件的線上遠端病理平台。

預計市場參與者之間日益增多的合作將推動預測期內的市場成長。例如，2022年9月23日，數位病理解決方案和臨床人工智慧應用供應商Paige AI公司與全玻片掃描器製造商OptraScan宣佈建立合作夥伴關係，旨在簡化美國、歐盟和英國數位病理技術的應用。兩家公司的目標是減少玻璃病理切片數位化過程中的障礙，從而改善腫瘤學和病理學的工作流程。

本次調查的主要特點

• 本報告對全球數位病理市場進行了詳細分析，提出了 2026 年至 2033 年預測期內的市場規模和複合年成長率，其中 2025 年為基準年。
• 此外，我們將確定每個細分市場的潛在商機，並說明該市場中具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究基於以下參數分析了全球數位病理市場的主要參與者：公司概況、產品系列、關鍵亮點、財務表現和策略。本研究涵蓋的主要參與者包括：徠卡生物系統努斯洛赫有限公司、Olympus Corporation、羅氏製藥有限公司、默克集團、通用電氣醫療集團、Mikroscan Technologies公司、皇家飛利浦公司、Sectra AB公司、Propath UK Limited公司、Inspirata公司、濱松光子株式會社、OracleBioel Limiteds）公司。
• 本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
• 《全球數位病理市場》報告的目標受群眾外包括行業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以利用各種用於分析全球數位病理市場的策略矩陣，更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場吸引力分析
  • 市場機遇
• 產品發布
• 併購和合作
• 監管準則和合規性
• 主要進展
• PEST分析
• 科技趨勢
• 波特的分析
• 價格分析（2026 年）

第4章 全球數位病理市場：依產品類型分類，2021-2033年

• 影像分析軟體
• 掃描器
• 服務

第5章 全球數位病理市場：依治療領域分類，2021-2033年

• 腫瘤學
• 血液學
• 自體免疫疾病
• 皮膚科
• 其他

第6章：全球數位病理市場：依技術分類，2021-2033年

• 免疫組織化學
• ISH,FISH
• 螢光
• 其他

第7章 全球數位病理市場：依最終用戶分類，2021-2033年

• 製藥和生物技術公司
• 診斷實驗室
• 醫院實驗室
• 其他（研究機構、專業中心等）

第8章 全球數位病理市場：按地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第9章 競爭情勢

• Leica Biosystems Nussloch GmbH
• Olympus Corporation
• F. Hoffmann-La Roche Ltd
• Merck KGaA
• GE Healthcare
• Mikroscan Technologies, Inc
• Koninklijke Philips NV
• Sectra AB
• Propath UK Limited
• Inspirata, Inc.
• Hamamatsu Photonics, Inc.
• OracleBio Limited
• MD Biosciences
• Aiforia
• Xybion Digital Inc.
• Nucleai, Inc

第10章

• 調查方法
• 關於本公司

Digital Pathology Market is estimated to be valued at USD 1,250.8 Mn in 2026 and is expected to reach USD 2,835.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.4% from 2026 to 2033.

Digital pathology is the process of digitizing glass slides using a whole slide image scanner and then analyzing the digital images using an image viewer, typically on a computer monitor or mobile device. Digital pathology offers a better viewing experience, which enhances analysis. This lowers diagnostic error rates. These tools additionally provide service providers immediate access to earlier cases for comparison. These advanced systems store data for use in long-term predictive analysis. Specimens are barcoded to reduce the chance of misidentification. Also, this removes concerns about lost data due to slide breakage. In the modern world, digital pathology has many benefits including improved disease diagnosis accuracy, quicker recovery times, increased pathologist productivity, and so on. As a result of these benefits, healthcare facilities are increasingly using digital pathology platforms for disease diagnosis, and major market players are getting involved in product launch process.

Market Dynamics

The use of new technologies for the development of innovative digital pathology platform is expected to drive the growth of the global digital pathology market over the forecast period. For instance, in June 2022, Tribun Health, a software company, launched TeleSlide Patho 5, an online telepathology platform which is utilized for sharing digital pathology slides and other multimedia documents.

Increasing number of partnerships by the market players is expected to drive the market growth over forecast period. For instance, on September 23, 2022, Paige AI, Inc., a provider of digital pathology solutions and clinical AI applications, and OptraScan, a producer of whole slide scanners, announced a partnership to streamline the adoption of digital pathology technology in the U.S., European Union countries, and U.K. The companies' goal is to lower obstacles to glass pathology slide digitization, which will improve oncology and pathology workflows.

Key features of the study

• This report will provide in-depth analysis of the Global Digital Pathology Market , and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2026 - 2033, considering 2025 as the base year
• It will elucidate potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Global Digital Pathology Market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Leica Biosystems Nussloch GmbH, Olympus Corporation, F. Hoffmann-La Roche Ltd., Merck KGaA, GE Healthcare, Mikroscan Technologies, Inc., Koninklijke Philips N.V., Sectra AB, Propath UK Limited, Inspirata, Inc., Hamamatsu Photonics, Inc., OracleBio Limited, MD Biosciences, Aiforia, Xybion Digital Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Global Digital Pathology Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Digital Pathology Market

Market Segmentation

• Product Type Insights (Revenue, USD Mn, 2026 - 2033)
• Image Analysis Software
• Scanner
• Services
• Therapeutic Area Insights (Revenue, USD Mn, 2026 - 2033)
• Oncology
• Hematology
• Autoimmune Disorders
• Dermatology
• Others
• Technology Type Insights (Revenue, USD Mn, 2026 - 2033)
• Immunohistochemistry
• ISH & FISH
• Immunofluorescence
• Others
• Industry Insights (Revenue, USD Mn, 2026 - 2033)
• Pharmaceutical and Biotechnology Companies
• Diagnostic Labs
• Hospital Laboratories
• Others
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Leica Biosystems Nussloch GmbH
• Olympus Corporation
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• GE Healthcare
• Mikroscan Technologies, Inc.
• Koninklijke Philips N.V.
• Sectra AB
• Propath UK Limited
• Inspirata, Inc.
• Hamamatsu Photonics, Inc.
• OracleBio Limited
• MD Biosciences
• Aiforia
• Xybion Digital Inc.
• Nucleai, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Therapeutic Area
  • Market Snapshot, By Technology
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
• Product Launches
• Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Key Developments
• PEST Analysis
• Technology Landscape
• PORTER's Analysis
• Pricing Analysis (2026)

4. Global Digital Pathology Market, By Product Type, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Image Analysis Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Scanner
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Bright Field Scanner
    • Fluorescence Scanner
• Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Installation and Integration
    • Maintenance Services
    • Consulting Services

5. Global Digital Pathology Market, By Therapeutic Area, 2021 -2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Hematology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Autoimmune Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Dermatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Digital Pathology Market, By Technology, 2021 -2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Immunohistochemistry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• ISH & FISH
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Immunofluorescence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Digital Pathology Market, By End User, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segments Trends
• Pharmaceutical & Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Diagnostic Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Hospital Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Others (Research Institutes, Specialty Centers, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Digital Pathology Market, By Region, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021 - 2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area , 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area , 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area , 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area , 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area , 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Leica Biosystems Nussloch GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Olympus Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• F. Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mikroscan Technologies, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Koninklijke Philips N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sectra AB
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Propath UK Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Inspirata, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Hamamatsu Photonics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• OracleBio Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• MD Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Aiforia
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Xybion Digital Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nucleai, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us